Yoshida, Daisuke
Shimokaze, Tomoyuki
Kondo, Atsushi
Toyoshima, Katsuaki
Saito, Tomoko
Article History
Received: 15 August 2021
Accepted: 22 February 2022
First Online: 20 April 2022
Declarations
:
: There was no relevant funding for this study.
: Written consent to participate in the study was obtained from the parents of the infants whose rSO<sub>2</sub> was measured in the maternity ward for the study. We routinely measured rSO<sub>2</sub> for clinical management purposes in infants admitted to the Neonatal Intensive Care Unit (NICU). Infants admitted to the NICU were not required to give informed consent for their participation in the study because the analysis used anonymized clinical data that were obtained after the guardian of each patient agreed to treatment by providing their written consent. We also adopted an opt-out system and posted a summary of the study on the hospital’s website (ExternalRef removed).
: The study was conducted in accordance with the principles contained within the Declaration of Helsinki and approved by the institutional review board of Kanagawa Children’s Medical Center (No. 1807-7, 2019).
: All the authors were responsible for diagnosis and the treatment of the patients. All the authors have read and approved the final version of the manuscript.
: All the authors are aware of the submission and agree that, if accepted, the manuscript and artwork will become the property of the publisher.